CarthaGenetics® focuses on rare diseases area with unmet needs. Good health is vital to all of us, and finding sustainable access to innovative treatments is our motto. That’s why we are committed to providing patients and physicians with innovative Orphan Drugs in development.
To ensure we can continue to deliver on our commitment to the patients, customers and shareholders who rely on us, we are focused on improving the way we do business; on operating with transparency in everything we do; and on listening to the views of all of people involved in healthcare decisions. Through working in partnership with everyone from patient groups to healthcare providers, healthcare authorities and non-governmental organizations, our goal is to ensure that people have access on time to innovative treatments.
We always act in an ethical manner, respecting patients’ rights and local legislations.